Next Article in Journal
Comparison of Adiposomal Lipids between Obese and Non-Obese Individuals
Next Article in Special Issue
Machine Learning Models Decoding the Association Between Urinary Stone Diseases and Metabolic Urinary Profiles
Previous Article in Journal
Analysis of Serum Exosome Metabolites Identifies Potential Biomarkers for Human Hepatocellular Carcinoma
Previous Article in Special Issue
Intake Biomarkers for Nutrition and Health: Review and Discussion of Methodology Issues
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative

by
Sandi L. Navarro
1,*,†,
Brian D. Williamson
2,3,4,†,
Ying Huang
3,4,5,
G. A. Nagana Gowda
6,
Daniel Raftery
6,
Lesley F. Tinker
1,
Cheng Zheng
7,
Shirley A. A. Beresford
1,8,
Hayley Purcell
6,
Danijel Djukovic
6,
Haiwei Gu
9,
Howard D. Strickler
10,
Fred K. Tabung
11,
Ross L. Prentice
1,4,
Marian L. Neuhouser
1,8,‡ and
Johanna W. Lampe
1,8,‡
1
Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
2
Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA
3
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
4
Department of Biostatistics, University of Washington, Seattle, WA 98195, USA
5
Biostatistics Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
6
Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA
7
Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA
8
Department of Epidemiology, University of Washington, Seattle, WA 98195, USA
9
Center for Metabolic and Vascular Biology, College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA
10
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
11
Department of Internal Medicine, Division of Medical Oncology, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
These authors contributed equally to this work.
Metabolites 2024, 14(8), 463; https://doi.org/10.3390/metabo14080463
Submission received: 26 July 2024 / Revised: 16 August 2024 / Accepted: 19 August 2024 / Published: 20 August 2024
(This article belongs to the Special Issue Metabolomics-Based Biomarkers for Nutrition and Health)

Abstract

Metabolomics has been used extensively to capture the exposome. We investigated whether prospectively measured metabolites provided predictive power beyond well-established risk factors among 758 women with adjudicated cancers [n = 577 breast (BC) and n = 181 colorectal (CRC)] and n = 758 controls with available specimens (collected mean 7.2 years prior to diagnosis) in the Women’s Health Initiative Bone Mineral Density subcohort. Fasting samples were analyzed by LC-MS/MS and lipidomics in serum, plus GC-MS and NMR in 24 h urine. For feature selection, we applied LASSO regression and Super Learner algorithms. Prediction models were subsequently derived using logistic regression and Super Learner procedures, with performance assessed using cross-validation (CV). For BC, metabolites did not increase predictive performance over established risk factors (CV-AUCs~0.57). For CRC, prediction increased with the addition of metabolites (median CV-AUC across platforms increased from ~0.54 to ~0.60). Metabolites related to energy metabolism: adenosine, 2-hydroxyglutarate, N-acetyl-glycine, taurine, threonine, LPC (FA20:3), acetate, and glycerate; protein metabolism: histidine, leucic acid, isoleucine, N-acetyl-glutamate, allantoin, N-acetyl-neuraminate, hydroxyproline, and uracil; and dietary/microbial metabolites: myo-inositol, trimethylamine-N-oxide, and 7-methylguanine, consistently contributed to CRC prediction. Energy metabolism may play a key role in the development of CRC and may be evident prior to disease development.
Keywords: breast cancer; colorectal cancer; metabolite predictors; dietary biomarkers; metabolomics breast cancer; colorectal cancer; metabolite predictors; dietary biomarkers; metabolomics
Graphical Abstract

Share and Cite

MDPI and ACS Style

Navarro, S.L.; Williamson, B.D.; Huang, Y.; Nagana Gowda, G.A.; Raftery, D.; Tinker, L.F.; Zheng, C.; Beresford, S.A.A.; Purcell, H.; Djukovic, D.; et al. Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative. Metabolites 2024, 14, 463. https://doi.org/10.3390/metabo14080463

AMA Style

Navarro SL, Williamson BD, Huang Y, Nagana Gowda GA, Raftery D, Tinker LF, Zheng C, Beresford SAA, Purcell H, Djukovic D, et al. Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative. Metabolites. 2024; 14(8):463. https://doi.org/10.3390/metabo14080463

Chicago/Turabian Style

Navarro, Sandi L., Brian D. Williamson, Ying Huang, G. A. Nagana Gowda, Daniel Raftery, Lesley F. Tinker, Cheng Zheng, Shirley A. A. Beresford, Hayley Purcell, Danijel Djukovic, and et al. 2024. "Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative" Metabolites 14, no. 8: 463. https://doi.org/10.3390/metabo14080463

APA Style

Navarro, S. L., Williamson, B. D., Huang, Y., Nagana Gowda, G. A., Raftery, D., Tinker, L. F., Zheng, C., Beresford, S. A. A., Purcell, H., Djukovic, D., Gu, H., Strickler, H. D., Tabung, F. K., Prentice, R. L., Neuhouser, M. L., & Lampe, J. W. (2024). Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women’s Health Initiative. Metabolites, 14(8), 463. https://doi.org/10.3390/metabo14080463

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop